IDIBELL-Bellvitge Biomedical Research Institute

The Bellvitge Biomedical Research Institute (IDIBELL) was created in 2004. It is the foundation that manages the research activities of Bellvitge University Hospital, the Catalan Oncology Institute, the Bellvitge campus of the University of Barcelona, and the public health companies Institut de Diagnòstic per la Imatge (Image Diagnosis Institute) and Banc de Sang i Teixits (Blood and Tissue Bank). The Institute is the core of Biopol, the health research park of Hospitalet de Llobregat, in the South of Barcelona. The president of the IDIBELL’s managing board is the Catalan Minister of Health, Marina Geli. IDIBELL has more than 500 researchers and manages a budget of almost 22 million euros. The Foundation’s main scientific partners are the University of Barcelona, the Catalan Oncology Institute and the Catalan Health Institute (the managing company of the Bellvitge University Hospital). Since March 2009, it is one of the five research centers accredited by the Spanish Ministry of Health.

Some content from Wikipedia, licensed under CC BY-SA

Why tumors become resistant to chemotherapy?

A common observation in oncology is the phenomenon that a patient with a tumor receives a drug and responds very well, but after a few months the cancer comes back and is now resistant to previously administered ...

Dec 02, 2013
popularity not rated yet | comments 0

'Dark genome' is involved in Rett Syndrome

Researchers at the Epigenetics and Cancer Biology Program at IDIBELL led by Manel Esteller, ICREA researcher and professor of genetics at the University of Barcelona, have described alterations in noncoding ...

May 02, 2013
popularity 3 / 5 (2) | comments 0